Digital therapeutics market is anticipated to witness a double digit CAGR from 2019 to 2030 and was valued at over US$ 140.0 Mn in 2018. It is anticipated to grow at a CAGR of 26.8% from 2019 to 2030.
The continual growth of the Digital Therapeutics market can be attributed to several factors, increasing use of smartphones and internet, increasing awareness related to digital health therapy, and rising number of chronic diseases & geriatric population. Moreover, need to curb the growing healthcare cost and provide better healthcare to population are other factors adding to the growth of the global digital therapeutics market between 2019 and 2030. To obtain better insights regarding the market scenario prominent players are increasingly focusing on collaborative initiatives with several institutes and research centers. Kaiku Health, a Helsinki-based company offering digital patient monitoring and patient-reported outcome services, collaborated with Turku University Hospital & Amgen (Finland) to launch a digital symptom tracking for multiple myeloma, a type of bone marrow cancer. This digital health therapy would support and guide patients in their treatment regime.
Major Key Players of the Digital Therapeutics Market are:
Pear Therapeutics, Proteus Digital Health, 2Morrow, Omada Health, Livongo Health, Ginger.Io, Noom, Mango Health, Canary Health, and Propeller Health among others.
No comments:
Post a Comment